Tamiflu was a blockbuster product for Roche over a ... Tamiflu has been approved in New Zealand as an OTC drug since 2007, and that will likely assist Sanofi as it tries to persuade the FDA ...

Sanofi’s (NASDAQ:SNY ... switch of Cialis tablets from a prescription-only medicine to an over-the-counter product. The company added that it is finalizing the clinical and regulatory work ...

Sanofi’s consumer healthcare business Opella has secured the FDA’s blessing to move forward with its ambition to convert its erectile dysfunction med Cialis into an over-the-counter product.

Zantac was originated by GSK and launched by the company in the early 1980s, which sold it as a prescription and over-the-counter (OTC) product for indications like heartburn and acid indigestion ...

In a report released on January 30, David Evans from Kepler Capital maintained a Hold rating on Sanofi (SNYNF – Research Report), with a price ...

(RTTNews) - Sanofi's Consumer Healthcare division ... from a prescription-only medication to an over-the-counter option. With this decision, the actual use trial can now proceed, marking Cialis ...